4//SEC Filing
Sazdanoff Catherine 4
Accession 0001213900-20-043371
CIK 0001728328other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 6:24 AM ET
Size
8.0 KB
Accession
0001213900-20-043371
Insider Transaction Report
Form 4
Sazdanoff Catherine
Director
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-12-16+7,000→ 7,000 totalExercise: $3.02Exp: 2025-12-15→ Common shares (7,000 underlying) - Award
Employee Stock Option (Right to Buy)
2020-12-16+11,000→ 11,000 totalExercise: $3.02Exp: 2025-12-15→ Common shares (11,000 underlying)
Footnotes (3)
- [F1]The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00.
- [F2]The options were granted on 12/16/2020 and will vest 100% on the one year anniversary of the grant date (Dec 16, 2021) or immediately prior to the next AGM, whichever is sooner.
- [F3]The options were granted on 12/16/2020 and will vest monthly as follows: 325 vest on 01/16/2021; and 305 vest on the 16th day of each of the following 35 months.
Documents
Issuer
InMed Pharmaceuticals Inc.
CIK 0001728328
Entity typeother
Related Parties
1- filerCIK 0001650901
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 6:24 AM ET
- Size
- 8.0 KB